Literature DB >> 1847450

Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus.

N Emi1, T Friedmann, J K Yee.   

Abstract

Mixed infection of a cell by vesicular stomatitis virus (VSV) and retroviruses results in the production of progeny virions bearing the genome of one virus encapsidated by the envelope proteins of the other. The mechanism for the phenomenon of pseudotype formation is not clear, although specific recognition of a viral envelope protein by the nucleocapsid of an unrelated virus is presumably involved. In this study, we used Moloney murine leukemia virus (MoMLV)-based retroviral vectors encoding the gene for neomycin phosphotransferase to investigate the interaction between the VSV G protein and the retroviral nucleocapsid during the formation of MoMLV(VSV) pseudotypes. Our results show that VSV G protein can be incorporated into the virions of retrovirus in the absence of other VSV-encoded proteins or of retroviral envelope protein. Infection of hamster cells by MoMLV(VSV) pseudotypes gave rise to neomycin phosphotransferase-resistant colonies, and addition of anti-VSV serum to the virus preparations completely abolished the infectivity of MoMLV(VSV) pseudotypes. It should be possible to use existing mutants of VSV G protein in the system described here to identify the signals that are important for the formation of MoMLV(VSV) pseudotypes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847450      PMCID: PMC239887     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

Review 1.  Progress toward human gene therapy.

Authors:  T Friedmann
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

2.  Mutants of the Rous sarcoma virus envelope glycoprotein that lack the transmembrane anchor and cytoplasmic domains: analysis of intracellular transport and assembly into virions.

Authors:  L G Perez; G L Davis; E Hunter
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

3.  Factors affecting long-term stability of Moloney murine leukemia virus-based vectors.

Authors:  L Xu; J K Yee; J A Wolff; T Friedmann
Journal:  Virology       Date:  1989-08       Impact factor: 3.616

Review 4.  Assembly of animal viruses at cellular membranes.

Authors:  E B Stephens; R W Compans
Journal:  Annu Rev Microbiol       Date:  1988       Impact factor: 15.500

5.  Variable stability of a selectable provirus after retroviral vector gene transfer into human cells.

Authors:  D J Jolly; R C Willis; T Friedmann
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

6.  Phenotypic mixing between group A arboviruses.

Authors:  B W Burge; E R Pfefferkorn
Journal:  Nature       Date:  1966-06-25       Impact factor: 49.962

7.  A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection.

Authors:  L M Albritton; L Tseng; D Scadden; J M Cunningham
Journal:  Cell       Date:  1989-05-19       Impact factor: 41.582

8.  Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant.

Authors:  M A Whitt; L Chong; J K Rose
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

9.  Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site?

Authors:  R Schlegel; T S Tralka; M C Willingham; I Pastan
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

10.  A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells.

Authors:  H Okayama; P Berg
Journal:  Mol Cell Biol       Date:  1983-02       Impact factor: 4.272

View more
  91 in total

1.  A large-scale insertional mutagenesis screen in zebrafish.

Authors:  A Amsterdam; S Burgess; G Golling; W Chen; Z Sun; K Townsend; S Farrington; M Haldi; N Hopkins
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

2.  Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.

Authors:  C Aiken
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range.

Authors:  J Dong; M G Roth; E Hunter
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

4.  Long-term engraftment and angiogenic properties of lentivirally transduced adipose tissue-derived stromal cells.

Authors:  Rosalinda Madonna; Roberto Bolli; Gregg Rokosh; Raffaele De Caterina
Journal:  Mol Biotechnol       Date:  2013-05       Impact factor: 2.695

5.  Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation.

Authors:  S A Stewart; B Poon; J Y Song; I S Chen
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor.

Authors:  J L Blond; D Lavillette; V Cheynet; O Bouton; G Oriol; S Chapel-Fernandes; B Mandrand; F Mallet; F L Cosset
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  Transduction efficiency of pantropic retroviral vectors is controlled by the envelope plasmid to vector plasmid ratio.

Authors:  Yong Chen; William M Miller; Ashok Aiyar
Journal:  Biotechnol Prog       Date:  2005 Jan-Feb

8.  Epithelial stem cells as mucosal antigen-delivering cells: A novel AIDS vaccine approach.

Authors:  Robert White; Nicole Chenciner; Gregory Bonello; Mary Salas; Philippe Blancou; Marie-Claire Gauduin
Journal:  Vaccine       Date:  2013-11-25       Impact factor: 3.641

9.  Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus.

Authors:  M Suomalainen; H Garoff
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Transgenic cattle produced by reverse-transcribed gene transfer in oocytes.

Authors:  A W Chan; E J Homan; L U Ballou; J C Burns; R D Bremel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.